Collplant Holdings (CLGN) has released an update.
CollPlant Biotechnologies has published its first Environmental, Social, and Corporate Governance (ESG) and Sustainability Report, highlighting the company’s commitment to ethical operations and sustainable practices. The report emphasizes CollPlant’s focus on plant-based production to minimize emissions and its innovative non-animal-derived collagen technology aimed at advancing regenerative medicine while reducing environmental impact. CEO Yehiel Tal underscores the company’s dedication to impacting global health and enhancing corporate ESG practices as part of their vision for a sustainable future.
For further insights into CLGN stock, check out TipRanks’ Stock Analysis page.
